Home  > 
  Calcimedica gets fast track status for CRAC channel inhibitor 'CM4620' to treat acute pancreatitis,   May 26, 2017
  Takeda to present oncology portfolio through data presentations at upcoming meetings in Chicago, Madrid & Lugano,   May 26, 2017
  MorphoSys' licensee Janssen updates on development of guselkumab,   May 25, 2017
  Pembrolizumab approved in US for pancreatic cancers with mismatch repair deficiency,   May 25, 2017
  Otsuka, Proteus resubmit NDA to US FDA for digital medicine, Abilify,   May 25, 2017
  US FDA approves Kevzara to treat adult patients with active rheumatoid arthritis,   May 24, 2017
  Roche receives US FDA approval for Actemra/RoActemra injection for giant cell arteritis treatment,   May 24, 2017
  Merck’s sBLA for Keytruda to treat recurrent/advanced gastric/gastroesophageal junction adenocarcinoma gets US FDA priority review status,   May 24, 2017
  CHMP recommends approval of expanding use of Novartis' Zykadia in ALK-positive advanced NCLC,   May 22, 2017
  EMA committee recommends approval of LEO Pharma's brodalumab to treat adult patients with moderate-to-severe plaque psoriasis,   May 22, 2017
  Octapharma's Octagam 10% to treat dermatomyositis receives US FDA orphan drug status,   May 20, 2017
  Merck’s anti-PD-1 therapy Keytruda gets US FDA approval for patients with urothelial carcinoma,   May 20, 2017
  Amgen seeks US FDA approval for erenumab to prevent migraine,   May 20, 2017
  Vertex Pharma receives UFDA approval for Kalydeco for use in people with CF ages 2 and older,   May 19, 2017
  Abon Pharma receives US FDA approval for generic Clolar injection to treat relapsed/refractory ALL,   May 18, 2017
  US FDA grants priority review status to Bayer's copanlisib to treat relapsed/ refractory follicular lymphoma,   May 18, 2017
  Saudi FDA approves Sobi's Orfadin capsules to treat hereditary tyrosinemia type 1,   May 18, 2017
  US FDA grants breakthrough therapy status for Ignyta's entrectinib to treat adult with metastatic solid tumours,   May 17, 2017
  Systech announces webinar titled “The Clock is Ticking: Overcoming the Challenges of Implementing Serialization in the EU” on May 24,   May 17, 2017
  Boston completes acquisition of Swiss structural heart company, Symetis SA,   May 17, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |